Try a single issue or save on a subscription Issues delivered straight to your door or device ...

Learn More: What Causes Mild Obstructive Sleep Apnea? The main cause of OSA is obstruction, or blockage, of the upper airways ...

Mouth taping offers sleep benefits but has some potential risks. Learn how to mouth-tape safely and other options to reduce ...

Results showed that Zepbound significantly improved OSA symptoms and helped more participants achieve remission or mild OSA compared to placebo. Zepbound also led to significant weight loss ...

The potential market for such a device is significant. Mild OSA, which is characterized by the collapse of airways, is estimated to affect around one-fifth of adults. Sufferers may become tired ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.

001). Additionally, a greater proportion of patients treated with Zepbound achieved remission or mild nonsymptomatic OSA compared with those who received placebo (Study 5: 42.2% vs 15.9% ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The viral trend of mouth taping, popularized on platforms like TikTok and Instagram, is raising safety concerns among medical professionals.

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.